Skip to main content
SINGULAR HEALTH GROUP LTD logo

SINGULAR HEALTH GROUP LTD — Investor Relations & Filings

Ticker · SHG ISIN · AU0000129892 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 364 across all filing types
Latest filing 2021-04-18 Major Shareholding Noti…
Country AU Australia
Listing ASX SHG

About SINGULAR HEALTH GROUP LTD

https://singular.health/

Singular Health Group Ltd specializes in the development and commercialization of medical imaging software designed to enhance personalized healthcare. The company’s primary offering, the 3Dicom software suite, employs proprietary volume rendering technology to transform standard 2D DICOM files, such as CT and MRI scans, into immersive 3D visualizations. This platform supports surgical planning, remote clinical collaboration, and patient education by providing interactive anatomical models. Singular Health integrates artificial intelligence to automate image segmentation and diagnostic workflows, facilitating more precise clinical outcomes. Through its 'Scan to Surgery' initiative, the company bridges the gap between diagnostic imaging and physical intervention using virtual reality and 3D printing. Its solutions target medical practitioners, dental professionals, and healthcare institutions globally.

Recent filings

Filing Released Lang Actions
Ceasing to be a substantial holder 2 pages 81.8KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 605 Notice of ceasing to be a substantial holder under the Corporations Act 2001. It details changes in relevant interests and shareholdings of Regal Funds Management Pty Ltd in Singular Health Group Ltd, including dates and transaction details. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category of Major Shareholding Notification (MRQ). The document length is 3297 characters, which is consistent with a detailed notification rather than a brief announcement or a full report. Therefore, the correct classification is MRQ.
2021-04-18 English
Appendix 2A - release of restricted securities from escrow 16 pages 369.3KB
Capital/Financing Update Classification · 95% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It includes detailed information about the entity, the type of securities to be quoted, and the escrow period expiration. This form is a regulatory announcement related to capital markets and securities listing, specifically an application for quotation of securities. It is not a financial report, earnings release, or management discussion. It is also not a report publication announcement or certification. The document fits the category of Capital/Financing Update (CAP) because it relates to the issuance and quotation of securities, which is a capital market activity.
2021-04-06 English
Letter to Shareholders 2 pages 140.1KB
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice for a General Meeting of shareholders, detailing the meeting date, location, proxy voting instructions, and COVID-19 related arrangements. It does not contain financial statements, management discussion, or detailed report content. It is an announcement about the meeting and how shareholders can participate, not the actual meeting materials or results. The document length is under 5,000 characters and primarily serves as a notification. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2021-04-05 English
Notice of Extraordinary General Meeting/Proxy Form 23 pages 1.5MB
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Notice of Extraordinary General Meeting (EGM) and Explanatory Statement for Singular Health Group Limited. It includes details about the time, place, and agenda of the EGM, instructions on voting, proxy appointments, and resolutions to be considered by shareholders. The content focuses on seeking shareholder approval for a proposed transaction and share issuance related to the company's growth strategy. There are no financial statements, earnings data, or detailed management analysis present. The document is a formal meeting notice and explanatory material for shareholders to make informed voting decisions at the EGM. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings such as EGMs.
2021-04-05 English
R&D Tax Incentive Refund Received 2 pages 427.5KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 26 March 2021 from Singular Health Group Ltd. It reports the receipt of a $223,169 R&D tax incentive refund for the 30 June 2020 financial year and an additional retroactive COVID-19 cashflow boost payment of $59,032. The content focuses on the receipt of government funding and cashflow updates rather than detailed financial results or comprehensive reports. The document length is 3280 characters, which is relatively short and consistent with an announcement rather than a full report. There is no detailed financial data, no quarterly or annual financial statements, and no mention of management discussion or audit information. The nature of the content aligns best with a Capital/Financing Update (CAP) as it informs investors about a cash inflow related to government incentives and cashflow boosts, which affect the company's financing position. It is not a report publication announcement since it contains substantive information about the cash receipt itself, not just a notice of report availability.
2021-03-25 English
Restricted Securities to be Released from Escrow 1
Capital/Financing Update Classification · 95% confidence The document is an ASX release announcing the release of restricted securities from escrow and the subsequent application for quotation of these shares. It is a brief announcement related to capital structure changes but does not contain financial statements or detailed financial data. The document length is short (1041 characters), and it is an announcement rather than a full report. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to share release and quotation, which is a capital structure event.
2021-03-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.